CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $2,325,000 | -10.3% | 150,000 | 0.0% | 0.14% | -15.7% |
Q1 2017 | $2,591,000 | +57.1% | 150,000 | 0.0% | 0.17% | +60.7% |
Q4 2016 | $1,649,000 | -29.9% | 150,000 | 0.0% | 0.11% | -25.7% |
Q3 2016 | $2,352,000 | +53.5% | 150,000 | 0.0% | 0.14% | +53.2% |
Q2 2016 | $1,532,000 | -20.8% | 150,000 | 0.0% | 0.09% | -13.0% |
Q1 2016 | $1,935,000 | -7.3% | 150,000 | +50.0% | 0.11% | +3.8% |
Q4 2015 | $2,087,000 | – | 100,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 6,450,000 | $8,320,500 | 1.17% |
BVF INC/IL | 6,595,801 | $8,508,583 | 0.23% |
Bronte Capital Management Pty Ltd. | 925,245 | $1,193,566 | 0.12% |
Formidable Asset Management, LLC | 318,111 | $410,363 | 0.09% |
Congress Park Capital LLC | 112,450 | $145,061 | 0.08% |
Forefront Analytics, LLC | 49,421 | $63,754 | 0.04% |
Ground Swell Capital, LLC | 10,966 | $14,146 | 0.02% |
Clearline Capital LP | 196,583 | $253,592 | 0.02% |
CORNERCAP INVESTMENT COUNSEL INC | 81,352 | $104,944 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 2,646,190 | $3,412 | 0.01% |